His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...
When people high in narcissism feel slighted or criticized, it threatens their fragile or inflated self-esteem, prompting ...